Target intelligence / Profile preview

Interleukin-34 (IL-34)

Target
IL-34
Molecular classification
Cytokine, Interleukin, Secreted protein
01

Overview

Interleukin‑34 (IL‑34) is a secreted cytokine composed of 241 amino acids that forms homodimers. It belongs to the interleukin family and functions primarily by binding to the colony-stimulating factor 1 receptor (CSF‑1R), as well as other receptors such as PTP-zeta and syndecan‑1. Through these interactions, it promotes the growth, survival, differentiation, and function of monocytes and macrophages. IL‑34 plays key roles in tissue-specific development of myeloid cells—such as Langerhans cells in skin and microglia in brain—and regulates immune responses by influencing chemokine expression. Its expression is most abundant in spleen but also found across various tissues including thymus, liver, intestine, lung, heart, brain, kidney, testes and ovary. Alterations in its levels are implicated in disease pathogenesis including cancer progression (notably triple-negative breast cancer) and chronic inflammation[1][3][2][7].

Other names
IL-34IL34 proteinInterleukin 34IL-34 cytokine
02

Mechanism of action

Binds to colony-stimulating factor 1 receptor (CSF‑1R), activating signaling pathways that regulate proliferation, differentiation, survival of myeloid cells[3][1]

03

Biological functions

Immune responseCell proliferationCell survivalDifferentiation of monocytes and macrophages
04

Disease associations

Cancer (notably as a prognostic marker and drug target in triple-negative breast cancer)Inflammation
05

Safety considerations

Potential safety concerns may relate to immune modulation and effects on myeloid cell populations; detailed clinical safety data not specified in current sources.
06

Biomarkers

Prognostic marker for triple-negative breast cancer

Beyond the preview

Go deeper on Interleukin-34 (IL-34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-34 (IL-34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call